Charles River Associates (“CRA”) was asked by EFPIA and PhRMA to update the Comparison report undertaken in 2010/11 (CRA 2011).1 The overall purpose is to develop a neutral and objective description and comparison of health technology assessment (HTA), based on the stated methodologies that are used in systems, but also taking into account the actual behaviour of those involved and their observable impact.